European LifeCare

What European LifeCare does

European LifeCare Group A/S is a Denmark-headquartered, privately held healthcare services company that operates what it describes as Europe's largest independent network of travel and health vaccination clinics. Founded in 1998 and headquartered in Søborg, the group runs more than 170 owned and operated clinics across the United Kingdom and Denmark, supported by a clinical workforce of 1,060+ healthcare professionals. Its brand portfolio comprises six regional entities retained after acquisition: Danske Lægers Vaccinations Service and Blivvaccineret (Denmark), CityDoc and Vaccination UK (United Kingdom), Prevent Vaccins (European brand), and Vaccinaties Op Reis (Netherlands), giving it geographic and demographic reach that a single brand would not achieve organically.

The company delivers four core service lines. Travel Vaccination covers pre-trip immunization for international travelers, including specialty vaccines such as the Chikungunya vaccine it was first to launch in the UK in June 2025. Health Vaccination provides routine and seasonal immunization for the general population. Trials & Research supports pharmaceutical and healthcare partners with clinical trial execution, and Diagnostic Services provides disease-prevention and health-monitoring testing. The underlying technology is a clinic-based service delivery platform; no proprietary software stack, AI/ML capability, or external developer API is disclosed. The platform is operated primarily through owned physical clinics, with a new retail channel being built through a 2026 partnership with Lidl supermarkets to deliver vaccinations in non-traditional retail locations.

Revenue is generated largely through direct-to-consumer fee-for-service payments at clinics, augmented by long-standing contractual relationships with the NHS (over 20 years as a trusted partner), corporate clients, and research partners for clinical trial participation. Pricing is not publicly disclosed. The company is institutionally backed by Inflexion, a private equity firm that participated in a 2018 funding round, and is led by CEO Andrew Paulsen, co-founders Karsten and Keld Ostergaard, and group CFO Kristian Tuft. In 2025 the group reported 3.2 million vaccinations administered across its network.

Name

European LifeCare

Legal name

European LifeCare Group A/S

Website

https://europeanlifecaregroup.dk

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

11–50 employees

Short description

European LifeCare Group operates Europe's largest independent vaccination clinic network, delivering travel, health, diagnostic, and clinical-trial services through 170+ clinics in the UK and Denmark, with a 1,060-strong clinical workforce.

Ownership category

akta.pro rank

Product category

Vaccination and Preventive Healthcare Services

NAICS

Offices of Physicians (6211), All Other Ambulatory Health Care Services (62199)

SIC

Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Immunization & Vaccine Clinics (HLAKAGAJ)

akta.pro secondary industry

Health & Medical Risk Management (Vaccination Guidance, Telemedicine, Medical Networks) (THACAEAF)

Keywords

• Vaccination services
• Travel vaccination
• Preventive healthcare
• Diagnostic services
• Clinical trials

Headquarters

HQ city

Søborg

HQ country

Denmark

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Vaccination Services: Revenue generated from providing travel vaccinations and health vaccinations to individual consumers and corporate clients. Services are delivered through owned clinic network and partner locations.
2. Diagnostic Services: Revenue from diagnostic testing services complementing vaccination offerings, aimed at disease prevention and health monitoring.
3. Clinical Trials & Research: Revenue from conducting clinical trials and research in partnership with healthcare organizations and pharmaceutical companies.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

European LifeCare Group delivers preventive healthcare services through four core service lines: travel vaccinations for international travelers, general health vaccinations for disease prevention, diagnostic testing services, and clinical trials and research. These services are provided directly to consumers and institutional partners through a network of 170+ owned clinics across the UK and Denmark, supplemented by retail partnerships (e.g., Lidl) that bring vaccination services into everyday locations.

Product overview

European LifeCare Group operates as a unified healthcare platform offering preventive care services through a portfolio of distinct brands. The company provides four core service lines: Travel Vaccination, Health Vaccination, Trials & Research, and Diagnostic Services. These services are delivered through multiple sub-brands across different European markets - DLVS and Blivvaccineret in Denmark, CityDoc and Vaccination UK in the UK, Prevent Vaccins as a European brand, and Vaccinaties Op Reis in the Netherlands. The company operates over 170 clinics and has administered 3.2 million vaccinations in 2025, with 1060+ healthcare professionals delivering personalized care across the group.

Differentiator

Problem solved

Functional benefit

Brands

• Danske Lægers Vaccinations Service (DLVS): Danish vaccination service brand providing travel and health vaccinations
• Blivvaccineret
• CityDoc
• Vaccination UK (VUK)
• Prevent Vaccins
• Vaccinaties Op Reis (VOR)

Products and services

• Travel Vaccination Services Comprehensive travel vaccination services for individuals traveling internationally, providing preventive care against diseases common in destination countries; delivered through 170+ owned clinics in the UK and Denmark and includes specialty vaccines such as Chikungunya.
• Health Vaccination Services General health vaccination services for individuals, focused on disease prevention and public-health maintenance through routine and seasonal immunizations, delivered through the group's owned clinic network in the UK and Denmark.
• Diagnostic Services Diagnostic testing services complementing the group's vaccination offerings, providing disease-prevention and health-monitoring diagnostics to individual consumers and partners through the owned clinic network.
• Trials & Research Clinical trials and research services in partnership with healthcare organizations and pharmaceutical companies, supporting vaccine development and contributing to medical-science advancement, leveraging the group's large clinic footprint and patient base.

Quantifiable outcome

• 3.2 million vaccinations administered in 2025
• +2 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• LidlcoreChannel Partner/ Reseller/ Distributor · 9 June 2026Partnership with Lidl supermarket chain to bring vaccination services closer to everyday life. The partnership aims to increase accessibility of vaccination services by establishing locations in retail environments where customers shop regularly.

Scale indicators7 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Fleet Street Clinic (MASTA): Private London-based independent travel health and vaccination clinic chain (MASTA predecessor). Operates dedicated travel vaccination clinics in the UK, offering the same specialist vaccine panel (yellow fever, rabies, Japanese encephalitis, etc.) as ELCG and competing head-to-head for travellers and corporate duty-of-care contracts.
• Nomad Travel Store & Clinic: Specialist UK travel medicine retailer and clinic operator since the 1980s, providing travel vaccinations and travel health advice. Direct competitor in the specialist travel vaccination category with comparable (though smaller) clinic footprint and traveller persona.
• Central Health (formerly Dr Morton's): Private UK home-visit and clinic-based GP and travel health provider serving corporate and individual clients. Comparable corporate duty-of-care travel health offering and overlapping mid-premium price tier with ELCG's UK Vaccination UK and CityDoc brands.

Broad incumbents

• Boots Pharmacy (Travel & Health Vaccinations): UK high-street pharmacy chain with a large vaccination services programme (travel jabs, NHS flu, Covid-19). Overlaps with ELCG's consumer travel and health vaccination offering through dense physical-store reach and pharmacist-administered jabs, competing on convenience and price.
• Superdrug Health Clinics: UK high-street retailer's in-store nurse-led clinic network offering travel vaccinations and health screening. Competes for the same direct-to-consumer travel and preventive health customer segment, leveraging retail footfall similarly to ELCG's Lidl partnership.
• Capio / Ramsay Santé: Major European private healthcare operator (now part of Ramsay Santé) running multi-specialty clinics across the Nordics and continental Europe. Comparable multi-country clinic operator with adjacent preventive and occupational health services that could compete for the same corporate vaccination contracts.
• Falck A/S: Denmark-founded healthcare and emergency services group now spanning Europe, with occupational health, vaccinations, and pre-hospital services. Headquartered regionally adjacent to ELCG and competes for the same Danish workplace vaccination and preventive health contracts.

Regional players

• Terveystalo: Largest private healthcare service provider in Finland and broader Nordics, with extensive occupational health, vaccination, and diagnostics footprint. Direct Nordic counterpart in private preventive health at meaningful scale, and a logical benchmark for ELCG's potential Nordic expansion beyond Denmark.

Emerging players

• IQdoctor / Vaccination UK competitors: Smaller UK digital-first travel vaccination and at-home testing providers offering limited specialist travel vaccines. Emerging niche competitor attracting the more price-sensitive online researcher segment that ELCG also serves.
• Doccla / Zava: Digital health players offering remote consultations, at-home diagnostics, and asynchronous vaccination advice across Europe. Not a clinic operator, but a structural threat that could disintermediate ELCG on triage, pre-travel consultation, and follow-up if it builds direct vaccine delivery capability.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/european-lifecare-group

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries6 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about European LifeCare